CRIP2 and breast carcinoma: There was indeed a significantly higher expression of VEGF in all breast cancer cell lines tested (Figure 6A) compared to the normal MCF-10A cells, similar to the lower levels of CRIP2 in the breast cancer cells compared to MCF-10A (Supplementary Figure S2), as well as our previously reported VEGF protein expression in archival human breast cancer samples [9].